These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12361758)

  • 1. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered RNase P ribozymes are efficient in cleaving a human cytomegalovirus mRNA in vitro and are effective in inhibiting viral gene expression and growth in human cells.
    Zou H; Lee J; Umamoto S; Kilani AF; Kim J; Trang P; Zhou T; Liu F
    J Biol Chem; 2003 Sep; 278(39):37265-74. PubMed ID: 12867424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.
    Trang P; Lee M; Nepomuceno E; Kim J; Zhu H; Liu F
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5812-7. PubMed ID: 10811889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
    Sun X; Chen W; He L; Sheng J; Liu Y; Vu GP; Yang Z; Li W; Trang P; Wang Y; Hai R; Zhu H; Lu S; Liu F
    PLoS One; 2017; 12(10):e0186791. PubMed ID: 29059242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of an RNase P ribozyme against the mRNA encoding human cytomegalovirus protease inhibits viral capsid protein processing and growth.
    Trang P; Kim K; Zhu J; Liu F
    J Mol Biol; 2003 May; 328(5):1123-35. PubMed ID: 12729746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNase P ribozymes selected in vitro to cleave a viral mRNA effectively inhibit its expression in cell culture.
    Kilani AF; Trang P; Jo S; Hsu A; Kim J; Nepomuceno E; Liou K; Liu F
    J Biol Chem; 2000 Apr; 275(14):10611-22. PubMed ID: 10744757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
    Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
    J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered external guide sequences are highly effective in inducing RNase P for inhibition of gene expression and replication of human cytomegalovirus.
    Yang YH; Li H; Zhou T; Kim K; Liu F
    Nucleic Acids Res; 2006; 34(2):575-83. PubMed ID: 16432261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
    Trang P; Kilani A; Kim J; Liu F
    J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular expression of engineered RNase P ribozymes effectively blocks gene expression and replication of human cytomegalovirus.
    Kim K; Umamoto S; Trang P; Hai R; Liu F
    RNA; 2004 Mar; 10(3):438-47. PubMed ID: 14970389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid Proteins.
    Yang Z; Reeves M; Ye J; Trang P; Zhu L; Sheng J; Wang Y; Zen K; Wu J; Liu F
    Viruses; 2015 Jun; 7(7):3345-60. PubMed ID: 26114473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
    Trang P; Lee J; Kilani AF; Kim J; Liu F
    Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
    Trang P; Zhang I; Liu F
    Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the functional interchange between the IE1 and pp71 proteins of human cytomegalovirus and ICP0 of herpes simplex virus 1.
    Lu Y; Everett RD
    J Virol; 2015 Mar; 89(6):3062-75. PubMed ID: 25552717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of RNase P ribozyme for gene-targeting applications.
    Raj SM; Liu F
    Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.